KRT14 and neoplasm: TNBCs' are aggressive tumours with poor prognosis and have been reported to express High molecular weight cytokeratin (CK5/6, CK14 & CK17), epidermal growth factor receptor (EGFR), E-cadherin, and Androgen receptors (AR).